Consultation on Sunsetting of Narcotic Drugs Regulations

Feedback updated 7 Sep 2026

We asked

Between 22 June and 19 July 2026, the Department of Health, Disability and Ageing sought feedback on proposed remaking of the Narcotic Drugs Regulation 2016 and the Narcotic Drugs (Licence Charges) Regulation 2016 (legislative instruments), which are scheduled to sunset on 1 April 2027. 

The purpose of this consultation was to engage with stakeholders to determine if the current regulations are effectively fulfilling their intended purpose before they are remade. Only necessary changes arising from the consultation would be considered as part of the remaking process.

You said

We received 28 submissions from 27 stakeholders. Feedback from the consultation generated valuable feedback on a range of regulatory, policy and operational matters. The submissions raised a broad range of issues about the operation of the medicinal cannabis regulatory framework.

Of these submissions 15 were from Individuals, 8 from Current licence holders/applicants under the Narcotic Drugs Act 1967, and 5 were from Organisations/Companies or Businesses (this category included peak bodies). Current licence holders/applicants raised the broadest range of topics including:

  • the cost-recovery framework; 
  • information requirements for a new medicinal cannabis licence and permit application;
  • processing timeframes; and
  • calls for a risk-based notification process.

Organisations/Companies or Businesses were smaller in response numbers but raised issues clustered around guidance, cost recovery and fees, and licence and permit application and variation requirements. Processing timeframes, service standards and risk-based notification were raised by peak bodies.

Individuals were most concentrated on patient access and personal cultivation, followed by the cost of medicinal cannabis for patients.

We did

Outcome of the consultation

We appreciate the time and effort stakeholders put into their submissions. We have heard the feedback, including issues that go beyond the scope of remaking the sunsetting legislative instruments.

We have analysed the feedback received through the consultation. Many issues raised are complex and extend beyond the sunsetting instruments to primary legislation and regulatory practice. We do not intend to make changes beyond minor or necessary amendments required to remake the legislative instruments at this stage.

How feedback will be considered

Feedback received through this consultation that were outside of the scope of the remaking process will inform future policy consideration, together with feedback gathered through other stakeholder engagement.

Next steps

The immediate priority is to remake the legislative instruments before they expire, ensuring continuity of the regulatory framework. More significant regulatory amendments, changes to primary legislation, or policy and operational settings would require detailed policy analysis, further stakeholder consultation and government consideration. This policy and reform work would be considered separately, subject to government priorities, available resourcing and timeframes beyond the current sunsetting process.

Published responses

View submitted responses where consent has been given to publish the response.

Closed 19 Jul 2026

Opened 22 Jun 2026

Overview

The Department of Health, Disability and Ageing is consulting on the proposed remaking of the Narcotic Drugs Regulation 2016 and the Narcotic Drugs (Licence Charges) Regulation 2016 (legislative instruments), which are scheduled to sunset on 1 April 2027. The legislative instruments support the framework that governs the cultivation of cannabis and the manufacture of narcotic drugs for medicinal and scientific purposes, as well as related licensing charges administered by the Office of Drug Control (ODC).

Sunsetting

Legislative instruments are automatically repealed after a fixed period, subject to some exceptions. The automatic repeal is called sunsetting, and the Australian Government’s sunsetting provisions are set out in Part 4 of Chapter 3 of the Legislation Act 2003. Sunsetting provides the government opportunities to review legislative instruments to ensure laws and regulations remain efficient and effective.

Focus of this consultation

The purpose of this consultation is to engage with stakeholders to determine if the current regulations are effectively fulfilling their intended purpose before they are remade. Feedback received during this consultation will be considered as part of the sunsetting and remaking process.

Why your views matter

Participation in this consultation provides stakeholders with an opportunity to contribute to the development of regulations that may affect them. Engaging in the consultation process allows stakeholders to:

  • provide informed feedback on the legislative instruments
  • identify potential implications for their sector, operations, or community, and
  • support the creation of balanced and effective regulation through evidence-based input.

Stakeholder contributions are an important component of transparent and inclusive policy development. All submissions will be carefully considered to ensure the legislative instruments are well-informed and appropriately targeted.

Key dates and how to respond

Consultation Paper - Sunsetting of Narcotic Drugs Regulations

Narcotic Drugs Regulation 2016

Narcotic Drugs (Licence Charges) Regulation 2016

Audiences

  • Businesses
  • Commonwealth agencies
  • Community groups
  • General public
  • Local governments
  • Non-government organisations
  • Prescription medicines
  • State government agencies

Interests

  • Health and Medical Research
  • Legislation
  • Regulatory policy